If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

  • This share is currently suspended. It was suspended at a price of 440.00
  • There is currently no data for MRL

Transaction in Own Shares

31 Oct 2024 07:00

RNS Number : 3036K
Marlowe PLC
31 October 2024
 

31 October 2024

 

Marlowe plc

 

Transaction in Own Shares

 

Marlowe plc ("Marlowe" or the "Group"), the leader in business-critical services, announces that, in accordance with the terms of its share buyback programme announced on 22 May 2024, the Company has purchased 116,500 ordinary shares of 50 pence each in the capital of the Company (the "Shares") in the market at a volume weighted average price of 336.78 pence per Share through Cavendish Capital Markets Limited ("Cavendish"). The Shares acquired will, in due course, be cancelled.

 

 

Aggregated Information

 

Date of Purchase:

30/10/2024

Aggregate Number of Shares Purchased:

116,500

Lowest Price Paid per Share (pence):

336.78

Highest Price Paid per Share (pence):

336.78

Volume-Weighted Average Price Paid per Share (pence):

336.78

 

 

Following the cancellation of Shares, Marlowe will have 85,689,727 ordinary shares of 50 pence each in issue and no ordinary shares are held in treasury. This figure of 85,689,727 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Individual Transactions

Number of Shares purchased

Transaction price (pence per Share)

Time of transaction

Venue

116,500

336.78

16:59

AIMX

 

For further information:

 

 

 

Marlowe plc

Lord Ashcroft, Interim Non-Executive Chair

Adam Councell, Chief Financial Officer

Benjamin Tucker, Head of Investor Relations & Strategy

www.marloweplc.com

Tel: +44 (0)20 3813 8498

IR@marloweplc.com

 

Cavendish Capital Markets Limited (Nominated Adviser & Joint Broker)

Ben Jeynes

George Lawson

Tel: +44 (0)20 7220 0500

Investec Bank (Joint Broker)

Henry Reast

Oliver Cardigan

Tel: +44 (0)20 7597 5970

FTI Consulting

Nick Hasell

Alex Le May

Tel: +44 (0)20 3727 1340

 

About Marlowe plc

Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBRBDGDXXDGSG
Date   Source Headline
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20248:58 amRNSHolding(s) in Company
9th Dec 20248:14 amRNSHolding(s) in Company
9th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSInterim results for the six months to 30 Sept 2024
29th Nov 20244:30 pmRNSTotal Voting Rights
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:02 amRNSTransaction in Own Shares
14th Nov 20249:29 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSChange of Adviser
5th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20244:58 pmRNSTotal Voting Rights
1st Nov 20249:23 amRNSHolding(s) in Company
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20241:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 202411:40 amRNSBlock listing Interim Review
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 20244:32 pmRNSResult of Annual General Meeting
30th Sep 20244:18 pmRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSAGM Statement
23rd Sep 202410:23 amRNSFurther re Demerger of Optima Health
20th Sep 20244:30 pmRNSTotal Voting Rights
12th Sep 20247:00 amRNSDemerger of Occupational Health division
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.